Enter assignee name

% Expired Patents = 23.1

EPO Patents = 5

Trademarks = 3

Forward Citations = 6

Loading Chart...

3 inventors (with patents filed for the assignee):

Tong Wang (13 out of 23 patents)

Stephen Gately (13 out of 24 patents)

Paul Gonzales (3 out of 3 patents)

13 patents: Sort by Forward Citations

1. 12076401 - Benzamide and active compound compositions and methods of use (2024-09-03),

2. 11780816 - Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase (2023-10-10),

3. 11555039 - Amide compounds as kinase inhibitors, compositions and methods of treatment (2023-01-17),

4. 11420947 - (S)-n-hydroxy-2-(2-(4-methoxyphenyl)butanamido)thiazole-5-carboxamide and pharmaceutically acceptable salts thereof (2022-08-23),

5. 11236052 - Aminobenzimidazole derivatives, treatments, and methods of inhibiting histone deacetylase (2022-02-01),

6. 10881733 - Benzamide and active compound compositions and methods of use (2021-01-05),

7. 10807966 - Heterocyclic compounds as kinase inhibitors (2020-10-20),

8. 10780080 - Benzamide and active compound compositions and methods of use (2020-09-22),

9. 10633393 - Heterocyclic compounds as kinase inhibitors (2020-04-28),

10. 10590088 - 4-(benzimidazol-2-ylamino)benzamide derivatives and methods of synthesis thereof (2020-03-17),

11. 10584119 - Pyrazole compounds and methods of use thereof (2020-03-10),

12. 10392402 - Heterocyclic compounds as kinase inhibitors (2019-08-27),

13. 10131654 - Pyrazole compounds and methods of use thereof (2018-11-20),

Translational Drug Development, LLC, based in Scottsdale, AZ, specializes in advancing drug development processes through innovative research and technology. The company focuses on providing comprehensive solutions that bridge the gap between preclinical and clinical development, ensuring that therapeutic candidates are effectively translated into viable treatments. With expertise in various therapeutic areas, Translational Drug Development aims to enhance the efficiency and success rates of drug development, contributing to the advancement of healthcare solutions.

Profile summary based on public USPTO records.